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Abstract
Background: Chromatin-associated histone H2AX is a key regulator of the cellular responses to
DNA damage. However, non-nucleosomal functions of histone H2AX are poorly characterized.
We have recently shown that soluble H2AX can trigger apoptosis but the mechanisms leading to
non-chromatin-associated H2AX are unclear. Here, we tested whether stalling of DNA replication,
a common event in cancer cells and the underlying mechanism of various chemotherapeutic agents,
can trigger increased soluble H2AX.
Results: Transient overexpression of H2AX was found to lead to a detectable fraction of soluble
H2AX and was associated with increased apoptosis. This effect was enhanced by the induction of
DNA replication stress using the DNA polymerase α inhibitor aphidicolin. Cells manipulated to
stably express H2AX did not contain soluble H2AX, however, short-term treatment with
aphidicolin (1 h) resulted in detectable amounts of H2AX in the soluble nuclear fraction and
enhanced apoptosis. Similarly, soluble endogenous H2AX was detected under these conditions.
We found that excessive soluble H2AX causes chromatin aggregation and inhibition of ongoing
gene transcription as evidenced by the redistribution and/or loss of active RNA polymerase II as
well as the transcriptional co-activators CBP and p300.
Conclusion: Taken together, these results show that DNA replication stress rapidly leads to
increased soluble H2AX and that non-chromatin-associated H2AX can sensitize cells to undergo
apoptosis. Our findings encourage further studies to explore H2AX and the cellular pathways that
control its expression as anti-cancer drug targets.
Background
Chromatin-associated histone H2AX is a key regulator of
the cellular response to genotoxic stress and DNA double-
strand breaks [1-6]. H2AX is a core histone H2A variant
that is randomly incorporated into nucleosomes during
DNA replication. It differs from histone H2A by a unique
C-terminal tail that contains a highly conserved SQE
motif with a serine residue at position 139 [7]. Serine 139
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becomes rapidly phosphorylated in response to DNA
double strand breaks by protein kinases of the phosphati-
dylinositol 3-OH-kinase-related kinase (PI3KK) family
including ATM, ATR or DNA-PK [8-10]. The phosphor-
ylated form of H2AX has been referred to as γ-H2AX [2].
Several lines of evidence suggest that the main function of
histone H2AX is to orchestrate the DNA damage response
through interactions with BRCT repeat-containing pro-
teins that bind phosphorylated H2AX such as MDC1 [11-
13]. However, H2AX has also been implicated in a
number of other functions including inactivation of sex
chromosomes and control of sister chromatid recombina-
tion [14,15]. We have recently shown that histone H2AX
also has non-nucleosomal functions, specifically, pro-
apoptotic activities in gastrointestinal stromal tumor
(GIST) cells treated with the small molecule protein
kinase inhibitor imatinib mesylate (Gleevec) [16].
Previous studies in yeast have shown that histone levels
need to be tightly regulated and that high levels of non-
chromatin bound histones are cytotoxic [17]. Soluble his-
tones can accumulate when DNA replication and histone
incorporation into the newly synthesized chromatin
become uncoupled, for example after stalling of replica-
tion forks [17-19].
The present study was designed to determine the mecha-
nisms that lead to increased soluble H2AX. We found that
even short-term stalling of replication forks is sufficient to
cause an increase of soluble H2AX. Furthermore, we show
that transient overexpression of H2AX, but not H2A, pro-
motes apoptotic cell death. In addition, we demonstrate
that overexpression of H2AX leads to a nuclear redistribu-
tion and/or loss of the active form of RNA polymerase II
as well as the transcriptional co-activators CBP and p300.
Taken together, our results suggest a model in which rep-
lication stress leads to increased soluble H2AX, which sen-
sitize cells to undergo apoptosis in a process that involves
a shut-down of gene transcription.
Results
Replication stress induces soluble H2AX
To test whether DNA replication stress can induce soluble
H2AX, we used the human osteosarcoma cell line U-2 OS
that, unlike GIST cells, does not depend on a single onco-
genically activated tyrosine kinase such as KIT and has
bona fide normal DNA damage response pathways. Cells
were transfected with constructs encoding GFP-tagged
H2AX, mutant GFP-H2AX-S139A or empty GFP vector
[20]. Expression of overexpressed H2AX proteins was dis-
tinguishable from endogenous H2AX based on the
increased molecular weight (Fig. 1A). After transient trans-
fection (24 h), a considerable amount of GFP-tagged
H2AX proteins were detected in the soluble nuclear com-
partment (Fig. 1B; lanes S3, untreated, middle and right
panels). When these cells were treated with aphidicolin, a
DNA polymerase α inhibitor that induces stalling of rep-
lication forks, a rapid increase of soluble proteins was
detected in the S3 fractions within 1 h (Fig. 1B). The ribo-
nucleotide reductase inhibitor hydroxyurea (HU), which
induces replication stress through nucleotide depletion,
had a similar effect (data not shown). Treatment with
aphidicolin or HU also led to an increase of endogenous
H2AX in the soluble fractions (Fig. 1B). These results
highlight previous findings in yeast showing excess levels
of free histones in cells in which DNA replication and his-
tone deposition are uncoupled [17-19]. Transfection with
mutant H2AX in which the phosphorylation site at S139
has been abolished (H2AX-S139A) had a similar effect as
wild-type H2AX, suggesting that the increase of soluble
H2AX is not dependent on this phosphorylation site. To
test whether our results allow generalization, we tran-
siently transfected the human lung cancer cell line H1299
with GFP-tagged H2AX, H2AX-S139A and empty vector.
Treatment with aphidicolin for 1 h, also led to an
increased fraction of soluble H2AX indicating that his
response is not cell type specific (Additional File 1).
To further corroborate our results, U-2 OS cell popula-
tions stably expressing GFP-tagged H2AX, H2AX-S139A or
empty vector were generated. In stable cell populations,
H2AX was undetectable in S3 fractions from untreated
cells (Fig. 1C). However, treatment with aphidicolin for 1
h rapidly resulted in an increase of soluble H2AX and
H2AX-S139A (Fig. 1C; S3 fractions).
Taken together, these results show that transient stalling
of DNA replication forks is associated with an increase of
soluble histone H2AX.
Overexpression of H2AX sensitizes cells to undergo 
apoptosis
We next tested whether an increase of soluble H2AX can
lead to enhanced apoptosis. As shown in Fig. 1B, transient
overexpression (24 h) of H2AX is associated with a pro-
portion of H2AX remaining in the soluble nuclear frac-
tion. At the same time, we detected a significant 3.3-fold
increase of apoptotic cells (5.9%; p ≤ 0.001) in compari-
son to empty vector controls (1.8%; Fig. 2A,B). Apoptotic
cells were identified based on the characteristic nuclear
morphology including DNA condensation and fragmen-
tation and only GFP-positive, transfected cells were
counted (Fig. 2B). Likewise, overexpression of mutant
H2AX-S139A also caused a 3.8-fold increase of apoptotic
cells (6.9%; p ≤ 0.01; Fig. 2A,B). Hence, apoptosis induc-
tion does not critically depend on serine 139 phosphor-
ylation, which is underscored by the finding that cells
transfected with H2AX-S139A lacked immunostaining for
γ-H2AX but still underwent apoptosis (Fig. 2B; bottom
panels).Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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DNA replication stress induces soluble H2AX Figure 1
DNA replication stress induces soluble H2AX. (A) Immunoblot analysis for GFP of U-2 OS cells stably transfected with 
empty GFP vector (control), GFP-H2AX or GFP-H2AX-S139A for 24 h. (B,C) Immunoblot analysis of soluble nuclear (S3) and 
chromatin bound (P3) protein fractions obtained from U-2 OS cells transiently (B; 24 h) or stably (C) transfected with empty 
GFP vector, GFP-H2AX or GFP-H2AX-S139A and treated with 10 μM aphidicolin (APH) for 1 h to block DNA replication. 
Staining for GFP detects expression of tagged proteins, whereas staining for H2AX detects endogenous protein. Immunoblot 
for ORC2 is shown to rule out carry-over between fractions. Ponceau S staining demonstrates protein loading.Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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Overexpression of H2AX but not H2A leads to apoptotic cell death and stimulates apoptosis Figure 2
Overexpression of H2AX but not H2A leads to apoptotic cell death and stimulates apoptosis. (A) Quantification 
of apoptotic U-2 OS cells following transient overexpression of empty GFP vector, GFP-H2AX or GFP-H2AX-SA for 24 h. 
Only transfected, GFP-positive cells were counted. Apoptosis was scored based on the nuclear morphology. Each bar indicates 
mean + standard error of at least three independent experiments with at least 100 cells counted per experiment. (B) Fluores-
cence microscopic analysis of U-2 OS cells transiently transfected with empty GFP vector (control), GFP-H2AX or GFP-
H2AX-S139A for expression of γ-H2AX. Note the negative staining for γ-H2AX of a cell transfected with mutant H2AX-
S139A. Nuclei stained with DAPI. Scale bar indicates 10 μm. (C) Quantification of apoptotic cells in U-2 OS populations stably 
transfected with empty GFP vector, GFP-H2AX or GFP-H2AX-S139A and treated with 10 μM aphidicolin for 24 h. Each bar 
indicates mean + standard error of at least three independent experiments with at least 100 cells counted per experiment. (D) 
Fluorescence microscopic analysis of a U-2 OS cell transiently transfected with myc-H2A and stained with an anti-myc-tag anti-
body. Nucleus stained with DAPI. Scale bar indicates 10 μm. (E) Quantification of apoptotic U-2 OS cells following transient 
overexpression of empty myc-tag vector (control) or myc-H2A for 24 h. Each bar indicates mean + standard error of at least 
three independent experiments with at least 100 cells counted per experiment.Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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To determine whether replication stress sensitizes H2AX-
overexpressing cells to undergo apoptosis, we used U-2
OS cell populations stably expressing either empty GFP
vector, GFP-tagged H2AX or GFP-H2AX-S139A. Cells were
treated with aphidicolin for 24 h and the proportion of
apoptotic cells was assessed (Fig. 2C). A significant 2.2-
fold increase of apoptotic U-2 OS cells stably expressing
GFP-H2AX was detected from 4.5% in DMSO-treated con-
trols to 9.7% in aphidicolin-treated populations (p ≤
0.05). In addition, a significant 9.2-fold increase of apop-
totic cells was detected in U-2 OS cells stably expressing
GFP-H2AX-S139A from 0.5% in DMSO-treated controls
to 4.6% in aphidicolin-treated cells (p ≤ 0.0001). No
apoptotic cells were found in populations expressing
empty GFP vector, regardless of the drug treatment (Fig.
2C).
We tested next whether overexpression of core histone
H2A was able to stimulate apoptosis. Transiently trans-
fected cell populations were stained with an anti-myc-tag
antibody and assessed for apoptotic nuclear morphology.
The proportion of transfected cells was similar to H2AX-
transfected populations. No enhanced cell death was
detected when myc-tagged H2A was overexpressed under
transient conditions in comparison to empty myc-tag vec-
tor (Fig. 2D,E).
Taken together, these results indicate that overexpression
of histone H2AX, but not histone H2A, can sensitize cells
to undergo apoptosis.
Overexpression of H2AX causes chromatin aggregation
In order to determine the mechanisms that underlie
H2AX induced cell death, we performed a morphological
analysis of U-2 OS cells transiently transfected with empty
GFP vector, GFP-H2AX or GFP-H2AX-S139A (Fig. 3A).
Excessive amounts of histones have previously been
shown to result in non-specific binding to DNA and/or
chromatin leading to structural alterations [16,21]. In
transient transfection experiments, we detected an
increase of cells with aberrant chromatin aggregation
from 4% in empty vector controls to 17.2% in H2AX-
transfected cells (4.3-fold; p ≤ 0.001) and 14.8% H2AX-
S139A-transfected cells (3.7-fold; p ≤ 0.001; Fig. 3A,B). U-
2 OS cells transiently transfected with core histone H2A
showed a moderate increase of chromatin aggregation
from 5.5% in empty vector controls to 10.4% in H2A-
transfected cells that was not statistically significant (Fig.
3C). Chromatin aggregation induced by H2AX was not
equivalent to apoptosis since cells with chromatin aggre-
gation did not show TUNEL positivity as exemplified in
Fig. 3D (bottom panels).
Overexpression of histone H2AX is associated with a 
redistribution of components of the transcriptional 
machinery
We lastly asked whether chromatin aggregation induced
by overexpression of histone H2AX can lead to a downreg-
ulation of active gene transcription [16]. The majority of
cellular mRNA transcription is carried out by RNA pol II.
The C-terminal domain (CTD) of RNA pol II consists of
tandem heptad repeats with the consensus sequence
Y1S2P3T4S5P6S7  that become hyperphosphorylated and
hypophosphorylated during the transcription cycle. Phos-
phorylation at serine 5 is associated with transcription ini-
tiation whereas serine 2 phosphorylation is
predominantly found during transcription elongation
[22]. Active gene transcription can be visualized by
immunofluorescence microscopy against RNA pol II S2
and typically results in a fine granular nuclear staining
pattern (Fig. 4A; top panels) [23,24]. The transcriptional
co-activators CREB-binding protein (CBP) and p300 reg-
ulate RNA pol II-mediated gene transcription by connect-
ing sequence-specific transcription factors to the basal
transcription machinery [25]. These proteins display a
similar staining pattern during ongoing transcription as
RNA pol II. Transcriptional inhibition has been shown to
induce a redistribution of the S2 phosphorylated elongat-
ing form of RNA pol II (pRNA pol II S2) into speckled
nuclear domains and to lead to RNA pol II degradation
[26,27]. Likewise, CBP and p300 are redistributed into
nuclear speckles upon transcriptional inhibition [27].
We detected a significant increase of cells with redistribu-
tion of pRNA pol II S2 into nuclear speckles or loss of
pRNA pol II S2 expression below detection level by
immunofluorescence microscopy in cells ectopically
expressing H2AX (2.9-fold; 36.5%; p ≤ 0.05) or H2AX-
S139A (2.7-fold; 34.2%; p ≤ 0.005) when compared to
controls (12.5%; Fig. 4A,B). In the vast majority of these
cells, nuclear redistribution of RNA pol II S2 coincided
with chromatin aggregation (Fig. 4A; middle panels). No
significant effect on pRNA pol II S2 distribution was
detected when H2A-transfected cells were analyzed (Fig.
4A,B). In addition to pRNA pol II S2, we found the tran-
scriptional co-activator CBP to be displaced from chroma-
tin in cells transfected either with H2AX (3.2-fold
increase, 36%; p ≤ 0.05) or H2AX-S139A (2.1-fold
increase, 24%; p ≤ 0.01) in comparison to empty vector
controls (11.4%; Fig. 4D,E). Similar results were found
when cells were analyzed for expression of p300 (Fig. 4F).
Furthermore, pRNA pol II S2 was displaced from chroma-
tin after treatment with aphidicolin as shown by immu-
noblotting further corroborating the results obtained by
immunofluorescence staining (Fig. 4G). Since transcrip-
tion is required for cell viability, our results suggest that
the ability of H2AX to abrogate ongoing transcription
may sensitize cells to undergo apoptosis.Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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Discussion
Histone variant H2AX plays a pivotal role in the mainte-
nance of genome stability, in particular in the absence of
p53 [1,6,28]. We have previously shown that soluble his-
tone H2AX is involved in apoptosis induction in GIST
cells treated with the small molecule inhibitor imatinib
mesylate [16]. Here, we extend these results by showing
DNA replication stress as one mechanism that can lead to
an increase of the pool of soluble H2AX. We show that
overexpression of H2AX sensitizes cells to apoptosis in a
process that is associated with a disruption of ongoing
gene transcription as evidenced by a redistribution of
active RNA pol II as well as CBP and p300.
Our report raises a number of questions that warrant fur-
ther investigation. First, it is unclear why the overall level
of apoptosis in U-2 OS after transient overexpression of
H2AX is comparatively low (in the range of 5%) in com-
parison to GIST cells (approximately 40%) [16]. One pos-
sibility is that GIST cells are particularly sensitive to
increased non-chromatin associated H2AX because they
express oncogenic KIT. We have previously speculated
that KIT may constitutively downregulate H2AX, which
Overexpression of H2AX leads to aberrant chromatin aggregation and apoptosis Figure 3
Overexpression of H2AX leads to aberrant chromatin aggregation and apoptosis. (A) Fluorescence microscopic 
analysis of U-2 OS cells transiently overexpressing empty GFP vector (control) or GFP-H2AX for 24 h. Note the chromatin 
aggregation in cells transfected with H2AX. Nuclei stained with DAPI. Scale bar indicates 10 μm. (B,C) Quantification of U-2 
OS cells with chromosome aggregation 24 h after transfection with empty GFP vector (control in B), GFP-H2AX, GFP-H2AX-
S139A, empty myc-tag vector (control in C) or myc-H2A. Each bar indicates mean + standard error of at least three independ-
ent experiments with at least 100 cells counted per experiment. (D) TUNEL staining of U-2 OS cells transiently transfected 
with GFP-H2AX and either showing an apoptotic morphology (top) or chromatin aggregation (bottom). Note that the cell 
with chromatin aggregation is TUNEL-negative. Nuclei stained with DAPI. Scale bar indicates 10 μm.Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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H2AX leads to a redistribution of the transcriptional machinery Figure 4
H2AX leads to a redistribution of the transcriptional machinery. (A) Immunofluorescence analysis of U-2 OS cells for 
expression of pRNA pol II S2 (Covance, Berkeley, CA) 24 h after transfection with empty GFP vector (control), GFP-H2AX or 
myc-H2A. Note chromatin aggregation and the speckled pRNA Pol II S2 pattern in cells transfected with H2AX. Nuclei stained 
with DAPI. Scale bar indicates 10 μm. (B,C) Quantification of U-2 OS cells with redistributed or lost RNA pol II S2 expression 
24 h after transfection with empty GFP vector (control in B), GFP-H2AX, GFP-H2AX-S139A, empty myc-tag vector (control 
in C) or myc-H2A. Each bar indicates mean + standard error of at least three independent experiments with at least 100 cells 
counted per experiment. (D) Double-immunofluorescence analysis of U-2 OS cells for expression of pRNA pol II S2 and CBP 
(Santa Cruz, Santa Cruz, CA) 24 h after transfection with empty GFP vector (control) or GFP-H2AX. Note the severely 
reduced expression of pRNA pol II S2 and CBP in the H2AX-transfected cell. Scale bar indicates 10 μm. (E) Quantification of 
U-2 OS cells with reduced CBP expression 24 h after transfection with empty GFP vector (control), GFP-H2AX, or GFP-
H2AX-S139A. Each bar indicates mean + standard error of at least three independent experiments with at least 100 cells 
counted per experiment. (F) Double-immunofluorescence analysis of U-2 OS cells for expression of pRNA pol II S2 and p300 
24 h after transfection with empty GFP vector (control) or GFP-H2AX. Note the severely reduced expression of pRNA pol II 
and p300 in H2AX-expressing cells. Scale bar indicates 10 μm. (G) Immunoblot analysis of pRNA pol II S2 in soluble nuclear 
(S3) and chromatin bound (P3) protein fractions obtained from U-2 OS cells transiently transfected (24 h) with empty GFP 
vector, GFP-H2AX or GFP-H2AX-S139A and treated with 10 μM aphidicolin (APH) for 1 h to block DNA replication.Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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may render GIST cells particularly sensitive to its re-
expression (see also below). Second, despite our current
results the precise mechanisms that lead to soluble H2AX
remain unclear. Since the reagents used here induce stall-
ing of DNA replication forks, it is possible that the uncou-
pling of histone production and histone incorporation
into chromatin leads to excessive levels of free histones as
it has previously been suggested [17-19]. However, pro-
longed replication arrest can also cause DNA breakage
and hence the possibility that increased soluble H2AX is a
result of accelerated histone eviction during DNA dam-
age-associated chromatin reorganization cannot be dis-
missed [29]. Third, the precise mechanisms of apoptosis
induction by histone H2AX await further clarification.
Our results suggest that chromatin aggregation and tran-
scriptional shut down, which cannot be sustained for a
prolonged period of time without affecting cell viability,
are important. However, this is a relatively non-specific
mechanism and other, more direct, pro-apoptotic mecha-
nisms of H2AX may also be involved [30]. Although we
cannot rule out the possibility that release of histones
from cells undergoing apoptosis contributes to a certain
degree to the increase of soluble H2AX [31], the present
report provides additional evidence that soluble histone
H2AX is a cause for increased cell death and not simply a
consequence.
It is conceivable that replication stress is a frequent event
in tumor cells [32,33]. Given the potentially deleterious
consequences of excessive H2AX [16,17], one prediction
would be that mechanisms exist that regulate the pool of
non-chromatin-associated H2AX. Such mechanisms are
likely to involve the ubiquitin/proteasome machinery
since we have previously shown that H2AX can become
polyubiquitinated and that proteasome inhibition can
stabilize H2AX [16]. Recent findings show that the ubiq-
uitin-conjugating enzyme Ubc13 and the RING-finger
ubiquitin ligase RNF8 are involved in DNA damage-
induced H2AX ubiquitination [34-38]. Whether these
proteins are also involved in the modulation of H2AX lev-
els in tumor cells remains to be tested.
The fact that soluble H2AX induces apoptosis in tumor
cells opens new avenues for cancer therapy. Identification
of drugs that induce soluble H2AX, e.g. by inhibiting a
potential suppressor of H2AX, would be promising. Given
the role of the ubiquitin-proteasome system in the regula-
tion of H2AX levels in GISTs [16], it is also conceivable
that targeting the protein degradation machinery could
lead to increased soluble H2AX levels. Furthermore, the
GFP-tagged H2AX vectors could be used in a compound
screen with chromatin aggregation as the readout.
In summary, we report here that DNA replication stress
rapidly leads to an increase of soluble H2AX. Overexpres-
sion of H2AX was found to sensitize cells to undergo
apoptosis, which very likely involves the disruption of
ongoing gene transcription. Our findings encourage fur-
ther studies to exploit H2AX and the cellular mechanisms
that regulate its expression levels as novel anti-cancer drug
targets.
Conclusion
This report shows that stalling of DNA replication leads to
an increase of soluble H2AX in human tumor cells. Solu-
ble H2AX was found to sensitize cells to undergo apopto-
sis and this activity was associated with a transcriptional
shut-down. These results encourage further studies to
exploit histone H2AX and the mechanisms that regulate
its expression as anti-cancer drug targets.
Materials and methods
Cell culture and transfections
U-2 OS osteosarcoma cells and H1299 lung cancer cells
were obtained from ATCC (Manassas, VA) and main-
tained in Dulbecco's modified Eagle medium (DMEM;
Cambrex, Baltimore, MD) supplemented with 10% fetal
bovine serum (FBS; Mediatech, Herndon, VA), 50 U/ml
penicillin and 50 μg/ml streptomycin (both BioWhit-
taker, Baltimore, MD). Cells were transfected with an
empty GFP vector or N-terminal GFP fusion plasmids
encoding wild-type H2AX and H2AX in which serine 139
has been substituted by alanine (H2AX-S139A)[20] using
Fugene 6 (Invitrogen, Carlsbad, CA). In addition, empty
myc-tag vector or myc-H2A was used for transient overex-
pression experiments. Stable cell populations were gener-
ated by selecting cells in G418-containing media for 48 h.
Immunological Methods
Whole cell lysates were prepared by scraping cells into
RIPA buffer (1% NP-40, 50 mM Tris-HCl pH 8.0, 100 mM
sodium fluoride, 30 mM sodium pyrophosphate, 2 mM
sodium molybdate, 5 mM EDTA, 2 mM sodium
orthovanadate) containing protease inhibitors (10 μg/ml
aprotinin, 10 μg/ml leupeptin, 1 μM phenylmethylsulfo-
nyl fluoride). Suspensions were incubated for one hour at
4°C and cleared by centrifugation for 30 min at 14,000
rpm at 4°C. Protein concentrations were determined by
the Bradford assay (Biorad, Hercules, CA). 30 μg of pro-
tein were loaded on a 4–12% Bis-Tris gel (Invitrogen,
Carlsbad, CA) and blotted onto a nitrocellulose mem-
brane. Primary antibodies used were directed against GFP
(Lab Vision, Fremont, CA), H2AX (Bethyl Laboratories,
Montgomery, TX), ORC2 (BD Biosciences Pharmingen),
phosphorylated RNA pol II S2 (Covance, Berkeley, CA)
and actin (Sigma, St. Louis, MS).
For immunofluorescence micoscopic analyses, cells were
grown on coverslips, washed in PBS, fixed in 4% parafor-
maldehyde/PBS (15 min), permeabilized with 1% Triton-Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
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X 100/PBS (15 min) and blocked in 10% normal donkey
serum (Jackson Immunoresearch, West Grove, PA) for 15
min at room temperature. After incubation with primary
antibodies overnight at 4°C in a humid chamber, cells
were incubated with FITC-conjugated or Rhodamine Red-
conjugated secondary antibodies (Jackson Immunore-
search, 2 hours at 37°C) and counterstained with DAPI
(Vector Laboratories, Burlingame, CA). For double-
immunofluorescence analysis, cells were stained for the
first antigen followed by a second primary antibody and
an AMCA-labeled secondary antibody (Jackson Immu-
noresearch). Primary antibodies used for immunofluores-
cence stainings were directed against γ-H2AX (Trevigen,
Gaithersburg, MD), myc-tag (Cell Signaling, Danvers,
MA), phosphorylated RNA pol II S2 (Covance, Berkeley,
CA), CBP and p300 (both Santa Cruz, Santa Cruz, CA).
Cells were analyzed using an Olympus AX70 epifluores-
cence microscope equipped with a SpotRT digital camera.
Subcellular fractionation
Subcellular fractionation was performed according to
Mendez and Stillman [39]. Cells were trypsinized, col-
lected by centrifugation, washed with PBS, resuspended in
Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM
MgCl2, 10 mM NaF, 340 mM sucrose, 10% glycerol, 1 mM
DTT, 0.1 mM PMSF, 1 mM sodium orthovanadate, 0.1%
Triton-X 100, 5 μg/ml leupeptin 5 μg/ml aprotinin) and
incubated on ice for 5 minutes. The nuclei (P1) were col-
lected by low speed centrifugation at 1,300 g and lysed in
Buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, 0.1 mM
PMSF, 1 mM sodium orthovanadate, 5 μg/ml leupeptin, 5
μg/ml aprotinin) for 10 minutes on ice. The insoluble
chromatin fraction (P3) was collected by centrifugation at
1,700 g. The supernatant contained the soluble nuclear
proteins (S3). The chromatin pellet (P3) was resuspended
in SDS sample buffer and the DNA was sheared by sonica-
tion in a 550 Sonic Dismembrator (Fisher) at 15% ampli-
tude.
TUNEL staining
Apoptotic cells were visualized using the In Situ Cell
Death Detection Kit (Roche Applied Sciences, Indianapo-
lis, IN) according to manufacturer's instructions.
Statistical analysis
Statistical significance was assessed using Student's t test
for independent samples. P values ≤ 0.05 were considered
significant.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
YL, JAP and AC carried out the immunoblot and immun-
ofluorescence experiments and participated in the inter-
pretation of results. SD analyzed the immunofluorescence
experiments and participated in the design and interpreta-
tion of experiments. AD designed this study, participated
in the analysis of experiments and drafted the manuscript.
Additional material
Acknowledgements
We are grateful to Joseph S. Siino (University of California Davis School of 
Medicine, Davis, CA) and Nicolai Tomilin (Institute of Cytology, Russian 
Academy of Sciences, St. Petersburg, Russia) for the GFP-H2AX and GFP-
H2AX-S139A constructs and Brian Chadwick and Huntington F. Willard 
(Institute for Genome Sciences & Policy, Duke University, Durham, NC) 
for the H2A plasmid. This work was supported by the GIST Cancer 
Research Fund (GCRF), numerous private donations and a Research 
Scholar Grant from the American Cancer Society to A.D. (RSG-08-092-01-
CCG).
References
1. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC,
Monroe BC, Ciccone DN, Yan C, Vlasakova K, Livingston DM, Fergu-
son DO, Scully R, Alt FW: Increased ionizing radiation sensitiv-
ity and genomic instability in the absence of histone H2AX.
Proc Natl Acad Sci U S A 2002, 99:8173-8178.
2. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM: DNA dou-
ble-stranded breaks induce histone H2AX phosphorylation
on serine 139.  J Biol Chem 1998, 273:5858-5868.
3. Sedelnikova OA, Pilch DR, Redon C, Bonner WM: Histone H2AX
in DNA damage and repair.  Cancer Biol Ther 2003, 2:233-235.
4. Fernandez-Capetillo  O, Lee A, Nussenzweig M, Nussenzweig A:
H2AX: the histone guardian of the genome.  DNA Repair (Amst)
2004, 3:959-967.
5. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo
O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nus-
senzweig A: H2AX haploinsufficiency modifies genomic stabil-
ity and tumor susceptibility.  Cell 2003, 114:371-383.
6. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen
HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E,
Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-
Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenz-
weig MC, Nussenzweig A: Genomic instability in mice lacking
histone H2AX.  Science 2002, 296:922-927.
7. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W:
Histone H2A variants H2AX and H2AZ.  Curr Opin Genet Dev
2002, 12:162-169.
8. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ: ATM phos-
phorylates histone H2AX in response to DNA double-strand
breaks.  J Biol Chem 2001, 276:42462-42467.
Additional File 1
DNA replication stress induces soluble H2AX in H1299 lung carcinoma 
cells. Immunoblot analysis of soluble nuclear (S3) and chromatin bound 
(P3) protein fractions obtained from H1299 cells transiently transfected 
with empty GFP vector, GFP-H2AX or GFP-H2AX-S139A and treated 
with 10 μM aphidicolin (APH) for 1 h to block DNA replication. Stain-
ing for GFP detects expression of tagged proteins, whereas staining for 
H2AX detects endogenous protein. Immunoblot for ORC2 is shown to rule 
out carry-over between fractions. Ponceau S staining demonstrates protein 
loading.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
4598-7-61-S1.tiff]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Molecular Cancer 2008, 7:61 http://www.molecular-cancer.com/content/7/1/61
Page 10 of 10
(page number not for citation purposes)
9. Ward IM, Chen J: Histone H2AX is phosphorylated in an ATR-
dependent manner in response to replicational stress.  J Biol
Chem 2001, 276:47759-47762.
10. Park EJ, Chan DW, Park JH, Oettinger MA, Kwon J: DNA-PK is acti-
vated by nucleosomes and phosphorylates H2AX within the
nucleosomes in an acetylation-dependent manner.  Nucleic
Acids Res 2003, 31:6819-6827.
11. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bon-
ner WM: A critical role for histone H2AX in recruitment of
repair factors to nuclear foci after DNA damage.  Curr Biol
2000, 10:886-895.
12. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW,
Lee A, Bonner RF, Bonner WM, Nussenzweig A: Histone H2AX
phosphorylation is dispensable for the initial recognition of
DNA breaks.  Nat Cell Biol 2003, 5:675-679.
13. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jack-
son SP: MDC1 directly binds phosphorylated histone H2AX
to regulate cellular responses to DNA double-strand breaks.
Cell 2005, 123:1213-1226.
14. Fernandez-Capetillo O, Mahadevaiah SK, Celeste A, Romanienko PJ,
Camerini-Otero RD, Bonner WM, Manova K, Burgoyne P, Nussenz-
weig A: H2AX is required for chromatin remodeling and inac-
tivation of sex chromosomes in male mouse meiosis.  Dev Cell
2003, 4:497-508.
15. Xie A, Puget N, Shim I, Odate S, Jarzyna I, Bassing CH, Alt FW, Scully
R:  Control of sister chromatid recombination by histone
H2AX.  Mol Cell 2004, 16:1017-1025.
16. Liu Y, Tseng M, Perdreau SA, Rossi F, Antonescu C, Besmer P,
Fletcher JA, Duensing S, Duensing A: Histone H2AX is a mediator
of gastrointestinal stromal tumor cell apoptosis following
treatment with imatinib mesylate.  Cancer Res 2007,
67:2685-2692.
17. Gunjan A, Verreault A: A Rad53 kinase-dependent surveillance
mechanism that regulates histone protein levels in S. cerevi-
siae.  Cell 2003, 115:537-549.
18. Bonner WM, Wu RS, Panusz HT, Muneses C: Kinetics of accumu-
lation and depletion of soluble newly synthesized histone in
the reciprocal regulation of histone and DNA synthesis.  Bio-
chemistry 1988, 27:6542-6550.
19. Bonner WM, Mannironi C, Orr A, Pilch DR, Hatch CL: Histone
H2A.X gene transcription is regulated differently than tran-
scription of other replication-linked histone genes.  Mol Cell
Biol 1993, 13:984-992.
20. Siino JS, Nazarov IB, Svetlova MP, Solovjeva LV, Adamson RH, Zalen-
skaya IA, Yau PM, Bradbury EM, Tomilin NV: Photobleaching of
GFP-labeled H2AX in chromatin: H2AX has low diffusional
mobility in the nucleus.  Biochem Biophys Res Commun 2002,
297:1318-1323.
21. Steger DJ, Workman JL: Transcriptional analysis of purified his-
tone acetyltransferase complexes.  Methods 1999, 19:410-416.
22. Hahn S: Structure and mechanism of the RNA polymerase II
transcription machinery.  Nat Struct Mol Biol 2004, 11:394-403.
23. Jackson DA, Hassan AB, Errington RJ, Cook PR: Visualization of
focal sites of transcription within human nuclei.  Embo J 1993,
12:1059-1065.
24. Wansink DG, Schul W, van der Kraan I, van Steensel B, van Driel R,
de Jong L: Fluorescent labeling of nascent RNA reveals tran-
scription by RNA polymerase II in domains scattered
throughout the nucleus.  J Cell Biol 1993, 122:283-293.
25. Janknecht R, Hunter T: Transcription. A growing coactivator
network.  Nature 1996, 383:22-23.
26. Lee KB, Wang D, Lippard SJ, Sharp PA: Transcription-coupled and
DNA damage-dependent ubiquitination of RNA polymerase
II in vitro.  Proc Natl Acad Sci U S A 2002, 99:4239-4244.
27. von Mikecz A, Zhang S, Montminy M, Tan EM, Hemmerich P: CREB-
binding protein (CBP)/p300 and RNA polymerase II colocal-
ize in transcriptionally active domains in the nucleus.  J Cell
Biol 2000, 150:265-273.
28. Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M,
Gleason M, Bronson R, Lee C, Alt FW: Histone H2AX: a dosage-
dependent suppressor of oncogenic translocations and
tumors.  Cell 2003, 114:359-370.
29. Ikura T, Tashiro S, Kakino A, Shima H, Jacob N, Amunugama R, Yoder
K, Izumi S, Kuraoka I, Tanaka K, Kimura H, Ikura M, Nishikubo S, Ito
T, Muto A, Miyagawa K, Takeda S, Fishel R, Igarashi K, Kamiya K:
DNA damage-dependent acetylation and ubiquitination of
H2AX enhances chromatin dynamics.  Mol Cell Biol 2007,
27:7028-7040.
30. Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, Bode AM, Dong Z:
Cell apoptosis: requirement of H2AX in DNA ladder forma-
tion, but not for the activation of caspase-3.  Mol Cell 2006,
23:121-132.
31. Wu D, Ingram A, Lahti JH, Mazza B, Grenet J, Kapoor A, Liu L, Kidd
VJ, Tang D: Apoptotic release of histones from nucleosomes.
J Biol Chem 2002, 277:12001-12008.
32. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg
P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J:
DNA damage response as a candidate anti-cancer barrier in
early human tumorigenesis.  Nature 2005, 434:864-870.
33. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed
SI: Deregulation of cyclin E in human cells interferes with
prereplication complex assembly.  J Cell Biol 2004, 165:789-800.
34. Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas
C, Lukas J: RNF8 ubiquitylates histones at DNA double-strand
breaks and promotes assembly of repair proteins.  Cell 2007,
131:887-900.
35. Wang B, Elledge SJ: Ubc13/Rnf8 ubiquitin ligases control foci
formation of the Rap80/Abraxas/Brca1/Brcc36 complex in
response to DNA damage.  Proc Natl Acad Sci U S A 2007,
104:20759-20763.
36. Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD,
Panier S, Mendez M, Wildenhain J, Thomson TM, Pelletier L, Jackson
SP, Durocher D: Orchestration of the DNA-damage response
by the RNF8 ubiquitin ligase.  Science 2007, 318:1637-1640.
37. Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J: RNF8
transduces the DNA-damage signal via histone ubiquityla-
tion and checkpoint protein assembly.  Cell 2007, 131:901-914.
38. Zhao GY, Sonoda E, Barber LJ, Oka H, Murakawa Y, Yamada K, Ikura
T, Wang X, Kobayashi M, Yamamoto K, Boulton SJ, Takeda S: A crit-
ical role for the ubiquitin-conjugating enzyme Ubc13 in initi-
ating homologous recombination.  Mol Cell 2007, 25:663-675.
39. Mendez J, Stillman B: Chromatin association of human origin
recognition complex, cdc6, and minichromosome mainte-
nance proteins during the cell cycle: assembly of prereplica-
tion complexes in late mitosis.  Mol Cell Biol 2000, 20:8602-8612.